The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
ProShares
ETF
Equity
- years
8 holdings
$12.45
Price-4.88%
-$0.63
$2.300m
Small
$13.369k
Avg Volume$3.353m
$15.02
NAV0.95%
Expense Ratio4.82%
Yield$0.60
Dividend